Key result
A review of 20 articles indicates that remote monitoring of implantable electronic cardiovascular devices is safe and widely accepted, providing clinical advantages and patient satisfaction.
Why the study?
Does remote monitoring improve follow-up outcomes in patients with implantable electronic cardiovascular devices compared to traditional follow-up?
Does remote monitoring improve follow-up outcomes in patients with implantable electronic cardiovascular devices compared to traditional follow-up?
Remote monitoring of implantable electronic cardiovascular devices is a safe, widely accepted technology that offers clinical advantages and time savings, though technical, procedural, and legal issues remain.
Remote monitoring may ease IECD follow-up burden; leaves open need for prospective trials on outcomes.
Implantable electronic cardiovascular devices (IECD) include a broad spectrum of devices that have the ability to maintain rhythm, provide cardiac resynchronization therapy, and/or prevent sudden cardiac death. The incidence of bradyarrhythmias and other cardiac problems led to a broader use of IECD, which turned traditional follow-up into an extremely heavy burden for healthcare systems to support. Our aim was to assess the impact of remote monitoring on the follow-up of patients with IECD. We performed a review through PubMed using a specific query. The paper selection process included a three-step approach in which title, abstract, and cross-references were analyzed. Studies were then selected using previously defined inclusion criteria and analyzed according to the country of origin of the study, year, and journal of publication; type of study; and main issues covered. Twenty articles were included in this review. Eighty percent of the selected papers addressed clinical issues, from which 94% referred clinical events identification, clinical stability, time savings, or physician satisfaction as advantages, whereas 38% referred disadvantages that included both legal and technical issues. Forty-five percent of the papers referred patient issues, from which 89% presented advantages, focusing on patient acceptance/satisfaction, and patient time-savings. The main downsides were technical issues but patient privacy was also addressed. All the papers dealing with economic issues (20%) referred both advantages and disadvantages equally. Remote monitoring is presently a safe technology, widely accepted by patients and physicians, for its convenience, reassurance, and diagnostic potential. This review summarizes the principles of remote IECD monitoring presenting the current state-of-the-art. Patient safety and device interaction, applicability of current technology, and limitations of remote IECD monitoring are also addressed. The use of remote monitor should consider the selection of patients, the type of disease, and centers' availability to receive, interpret and respond to device alerts. Before remote IECD monitoring can be routinely used, technical, procedure, and ethical/legal issues should be addressed.
No takes yet. Share an insight, caveat, or question.
Costa et al. (2010) conducted a review in Implantable electronic cardiovascular devices (IECD) (n=20). Remote monitoring was evaluated on Impact of remote monitoring on follow-up (clinical, patient, and economic issues). A review of 20 articles indicates that remote monitoring of implantable electronic cardiovascular devices is safe and widely accepted, providing clinical advantages and patient satisfaction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: